Hypothalamic inflammation and gliosis in obesity : Current Opinion in Endocrinology, Diabetes and Obesity

Journal Logo

OBESITY AND NUTRITION: Edited by Caroline Apovian

Hypothalamic inflammation and gliosis in obesity

Dorfman, Mauricio D.; Thaler, Joshua P.

Author Information
Current Opinion in Endocrinology & Diabetes and Obesity 22(5):p 325-330, October 2015. | DOI: 10.1097/MED.0000000000000182
  • Free

Abstract

Purpose of review 

Hypothalamic inflammation and gliosis are recently discovered mechanisms that may contribute to obesity pathogenesis. Current research in this area suggests that investigation of these central nervous system responses may provide opportunities to develop new weight loss treatments.

Recent findings 

In rodents, hypothalamic inflammation and gliosis occur rapidly with high-fat diet consumption prior to significant weight gain. In addition, sensitivity or resistance to diet-induced obesity in rodents generally correlates with the presence or absence of hypothalamic inflammation and reactive gliosis (brain response to injury). Moreover, functional interventions that increase or decrease inflammation in neurons and glia correspondingly alter diet-associated weight gain. However, some conflicting data have recently emerged that question the contribution of hypothalamic inflammation to obesity pathogenesis. Nevertheless, several studies have detected gliosis and disrupted connectivity in obese humans, highlighting the potential translational importance of this mechanism.

Summary 

There is growing evidence that obesity is associated with brain inflammation in humans, particularly in the hypothalamus where its presence may disrupt body weight control and glucose homeostasis. More work is needed to determine whether this response is common in human obesity and to what extent it can be manipulated for therapeutic benefit.

INTRODUCTION

Over the past three decades, the increased consumption of high calorie ‘Western’ diets along with an ever-more sedentary lifestyle has led to over two-thirds of US adults being currently overweight or obese (BMI > 25 kg/m2). This trend is particularly concerning due to the strong association of obesity with serious chronic health conditions including diabetes, hypertension, and cardiovascular disease. Few pharmacologic therapies are available that show success in sustaining weight loss over the long term [1], and gastric bypass surgery is an effective but risky procedure that can be offered realistically to only a small number of obese individuals. Thus, new strategies to combat the obesity epidemic are urgently needed, but gaps in our understanding of body weight control continue to limit progress toward this goal.

Body weight is maintained in homeostatic equilibrium by balancing changes in fat mass with compensatory alterations in energy balance [2]. This system of energy homeostasis critically depends on the action of leptin, a hormone secreted from adipose tissue in proportion to body fat content. Leptin signals in the brain largely at the level of the hypothalamus, modulating the activity of specific neuronal subsets [including the orexigenic Agouti-related peptide (AgRP) and anorexigenic pro-opiomelanocortin (POMC) neurons] to reduce appetite and increase energy expenditure [3]. This allows lean individuals to maintain stable body weights over many years [4] but fails to protect obese individuals from the deleterious effects of highly palatable, calorie-dense foods and sedentary lifestyles. This differential susceptibility results not from leptin deficiency in obese individuals but rather from an acquired insensitivity to leptin action [5], akin to the central pathogenic role of insulin resistance in type 2 diabetes. In this light, investigations into the potential origins of leptin resistance have drawn inspiration from several decades of research into the mechanisms underlying insulin resistance, focusing particularly on the link between inflammation and impaired hormonal signaling. Beginning with the discovery of hypothalamic inflammation in obese rodents 10 years ago [6▪▪], this area of investigation has led to the hypothesis that obesity progression involves a complex multicellular process involving inflammatory signaling, neuronal stress, and reactive gliosis. In this article, we will summarize recent findings on hypothalamic inflammation, the specific central nervous system (CNS) cell types involved in this process, the relevance of injury and inflammation to obesity pathogenesis, and the evidence for similar mechanisms in human obesity.

F1-2
Box 1:
no caption available

HYPOTHALAMIC INFLAMMATION

An association between obesity and low-grade peripheral inflammation was discovered two decades ago with the identification of increased tumor necrosis factor-alpha (TNF-α) expression in the adipose tissue of obese rodents and humans [7]. Subsequent work demonstrated that this response includes numerous cytokines and chemokines beyond TNF, is required for obesity-associated insulin resistance, and is propagated by infiltrating macrophages and a variety of other recruited leukocyte cell types [8,9]. Based on these findings, the group of Lício Velloso at the State University of Campinas in Brazil was the first to identify a similar inflammatory response in the hypothalamus [6▪▪]. Long-term feeding of a lard-based high-fat diet (HFD) to rats increased mediobasal hypothalamic activation of the inflammatory signaling intermediates c-Jun N-terminal kinase (Jnk) and nuclear factor-κB (NF-κB), resulting in the production of proinflammatory cytokines [TNF-α, interleukin (IL)-1β, and IL-6] and impairment in insulin and leptin signaling. This initial description of hypothalamic inflammation has been reproduced by many other investigators, with extension of the finding to obese mice and nonhuman primates [10–13,14▪,15▪▪,16,17,18▪▪]; models of neonatal overfeeding, type 1 diabetes, and aging [19–22]; and other hypothalamic nuclei and the hippocampus [19,23,24]. In addition, HFD-induced inflammation has been associated with hypothalamic resistance to growth hormone and ghrelin signaling [25,26] and the development of obesity-associated diseases including cognitive dysfunction [27,28], hypertension [29], hepatic steatosis [30], beta cell dysfunction [31], and, through noncanonical transforming growth factor-beta (TGF-β) signaling, glucose intolerance [32▪]. Thus, hypothalamic inflammation represents a unifying mechanism of diet-induced obesity (DIO) and metabolic disease.

DIETARY AND CELLULAR MEDIATORS OF HYPOTHALAMIC INFLAMMATION

As mentioned above, the mediobasal hypothalamus is a primary CNS center of metabolic control. Remarkably, the presence of fenestrated capillaries and specialized tanycytes in the median eminence enable this area of the brain to sense and respond rapidly to circulating nutrient and hormonal mediators [33▪]. This has led to the suggestion that specific macronutrient components – in particular, free fatty acids derived from dietary lipid – are responsible for triggering the inflammatory process. With HFD feeding, mice accumulate a number of fatty acid species in the hypothalamus, including triacylglycerols, diacylglycerols, and ceramides [34]. Furthermore, acute intracerebroventricular infusion of lipids such as the saturated fatty acid palmitate and the ω-6 polyunsaturated arachidonate induces inflammatory signaling [11,35–37], alters autophagic protection from cellular stress [38], increases the unfolded protein response in the endoplasmic reticulum [39,40▪▪], promotes insulin and leptin resistance [11,41], and possibly triggers apoptosis [42]. Likewise, lipid ingestion via milk fat gavage or butter-based HFD consumption increases the hypothalamic levels of saturated fatty acids and proinflammatory gene expression without evidence of systemic inflammation [15▪▪,17]. In addition to fatty acids, several recent studies have suggested that hyperglycemia and fructose exposure can also induce hypothalamic inflammation [21,43], raising the possibility that nutrient excess itself may be the primary driver of the inflammatory process. Translating these findings to humans is challenging, however, as diet composition, dietary metabolism, and immune function differ greatly between species [44,45▪].

As described above, HFD-induced inflammation in peripheral tissues is tightly associated with infiltration of leukocytes – most notably, classically activated (M1) proinflammatory macrophages [8]. In contrast, whether a similar process occurs in the CNS is controversial. In theory, leukocytes cannot enter the brain due to blood–brain barrier (BBB) impermeability to diapedesis. Nevertheless, several groups have reported increased numbers of M1-type macrophages in the brains of HFD-fed rodents [46,47]. However, these studies used irradiation-induced myeloablation and bone marrow transplantation to provide tagged donor macrophages, an approach known to compromise the BBB and allow inappropriate ingress of circulating monocytes [48,49]. More recent approaches that included head shielding during irradiation demonstrated the near-complete absence of donor-derived macrophages [15▪▪], indicating that CNS resident cells must be responsible for HFD-induced hypothalamic inflammation. Indeed, the cellular response to HFD in the hypothalamus involves reactive gliosis [15▪▪,18▪▪,50], the CNS-specific process of recruitment, proliferation, and morphological transformation of astrocytes and microglia (CNS macrophages) in response to brain injury [51]. These changes can be observed as early as 24 h after the initiation of hypercaloric feeding [18▪▪] and are maintained during prolonged HFD consumption [15▪▪,18▪▪,50]. Interestingly, hypothalamic gliosis reverses with diet switch, resolving 4 weeks after restarting normal chow feeding [52▪]; in contrast, caloric restriction of HFD-fed animals does not ameliorate microglial accumulation and activation [53▪] (MDD and JPT, unpublished observation), suggesting diet composition is an important determinant of gliosis development. As in other neurodegenerative, infectious, and vascular diseases, HFD-induced reactive gliosis represents an active response to neuron injury [18▪▪], altering neuronal POMC neurovascular coupling through ensheathment of synapses [54], modifying neurotransmitter dynamics through altered astrocyte expression of glutamate and glucose transporters [55], and changing the firing activity of POMC and Neuropeptide Y (NPY) neurons [56▪]. Eventually, HFD exposure results in loss of POMC neurons [18▪▪], reduced hypothalamic neurogenesis [57], and impaired synaptic plasticity [54], all potential contributors to excess weight gain. Together, these studies suggest the possibility that glial cells play a primary role in obesity pathogenesis.

Although a new area of investigation, a number of studies have pointed to an active role of glial cells in the control of energy homeostasis. Both astrocyte leptin signaling and overall astrocyte activation can regulate feeding behavior under basal and ghrelin-stimulated conditions [58▪,59▪]. Tanycytes – specialized glial cells of the median eminence that contribute to BBB transport and can serve as neural progenitors – promote weight gain during HFD feeding both by limiting leptin access to the mediobasal hypothalamus [33▪] and by producing new neurons that increase food intake and decrease energy expenditure [60]. Likewise, the oligodendrocyte progenitor cell (OPC) functions through its proliferation/maturation proteoglycan NG2 to increase body weight and fat mass [61]. Finally, microglia are critical mediators of HFD-induced inflammatory signaling, modulating hypothalamic neuronal activity and food intake both during basal and HFD feeding [15▪▪,46,56▪] (MDD and JPT, unpublished data). These data notwithstanding, it should be noted that obesogenic diet consumption is associated with nearly instant glutamate release in the mediobasal hypothalamus, likely stimulated by orosensory perception of food [62], suggesting that glutamatergic neurons themselves may be the primary responders to HFD.

Contribution of hypothalamic inflammation to obesity pathogenesis

Hypothalamic inflammation is a robust and reproducible response to HFD feeding in rodent models, but its relevance as an obesity mechanism is still unclear. In favor of a causative role, hypothalamic inflammation occurs prior to obesity onset within the first few days of HFD feeding [18▪▪]. Moreover, blocking the NF-κB pathway in all CNS neurons, only hypothalamic neurons, or AgRP neurons exclusively reduces levels of HFD-induced leptin resistance and weight gain [40▪▪,63]. Similarly, preventing Toll-like receptor 4 (TLR4) signaling with blocking antibodies or through deletion of MyD88, a TLR and IL-1 signaling intermediate, improves hypothalamic leptin and insulin sensitivity and limits DIO [35,41]. Conversely, deletion of gamma-aminobutyric acid (GABA) B receptors from POMC neurons results in obesity and increased hypothalamic inflammation [64]. Likewise, infusion of low-dose TNF-α or viral activation of neuronal NF-κB signaling promotes hyperphagia and weight gain [40▪▪,65]. These data collectively suggest that in some contexts, hypothalamic inflammation is both necessary and sufficient for DIO.

Glial cell inflammation may also contribute to DIO. The use of a virally expressed dominant negative blocker of NF-κB signaling in astrocytes prevents the acute astrocytosis response induced by HFD [66] while depletion of microglia with a colony-stimulating factor-1 receptor (CSF-1R) antagonist reduces food intake in the setting of excess saturated fat ingestion [15▪▪]. However, not all forms of obesity require hypothalamic inflammation and gliosis. For example, leptin-deficient ob/ob mice become extremely obese on regular chow without gliosis [53▪]. Nevertheless, exposing ob/ob mice to HFD feeding increases leptin resistance, weight gain, microglial activity, and hypothalamic inflammation [53▪,67], suggesting that DIO sensitivity correlates with hypothalamic inflammation and gliosis. As another example, HFD-fed male C57BL6 mice are highly DIO sensitive due to increased hypothalamic inflammation from reduced estrogen signaling in neurons and astrocytes [14▪]. Conversely, female C57Bl6 mice and other DIO resistant models (e.g., DIO-R rats) lack central inflammatory and gliosis responses [14▪,46,68,69]. Recently, we discovered a sex-specific microglial switch for DIO susceptibility using a mouse model that lacks the fractalkine/CX3CL1 receptor CX3CR1 (MDD and JPT, unpublished data). CX3CL1, a chemokine secreted by neurons to maintain microglial quiescence, increases in the hypothalamus of females exposed to HFD. Remarkably, HFD-fed female Cx3cr1 knockout mice develop hypothalamic microglial activation and obesity compared to their heterozygous littermates. Conversely, HFD-fed males treated with a CNS CX3CL1 infusion have reduced microgliosis and weight gain in a CX3CR1-dependent manner, suggesting that HFD-induced microglial inflammatory activation contributes to obesity pathogenesis.

CONFLICTING DATA

Although substantial evidence suggests that hypothalamic inflammation and gliosis are associated with HFD-induced obesity, recent studies cast doubt on their causal role in the pathogenesis of DIO. First, it has long been known that total-body proinflammatory cytokine and cytokine receptor knockout models (e.g., IL-1, IL-6, IL-1 receptor, and TNF receptors) display obesity phenotypes rather than being protected from DIO. Second, several studies have demonstrated dissociation between weight changes and alterations in hypothalamic inflammation. In the first, DIO-sensitive HFD-fed rats switched back to regular chow for 8 weeks lose their excess weight despite sustained elevations in hypothalamic inflammatory gene expression [69]. Similarly, chronic ghrelin treatment increases adiposity while reducing hypothalamic inflammation and gliosis [70]. Conversely, neuronal peroxisome proliferator-activated receptor-δ and growth hormone receptor knockout mice are resistant to HFD-induced hypothalamic inflammation and gliosis yet more susceptible to DIO than wild-type controls [71]. Finally, a stereological analysis of the hypothalamus in HFD-fed mice revealed minimal evidence of neuronal loss and sustained gliosis though the diet composition and duration were different than prior studies [72▪]. Thus, the evidence supporting a direct role of hypothalamic inflammation and gliosis in promoting weight gain is clearly mixed. These considerations highlight the importance of determining whether hypothalamic inflammation and injury occurs in humans and contributes to obesity pathogenesis.

HYPOTHALAMIC DISEASE IN HUMANS?

Although the extent to which obesity and/or HFD feeding impacts hypothalamic structure and function in humans remains uncertain, translational insights using brain imaging are beginning to support this type of neuropathologic model. A retrospective analysis of MRIs from 34 patients (BMI range: 17.7–44.1 kg/m2) revealed evidence of gliosis in the mediobasal hypothalamus that correlated with BMI [18▪▪], and recently the findings were replicated in a prospective cohort showing an additional link between gliosis and insulin resistance (Ellen Schur, personal communication). A separate MRI study in 44 overweight/obese patients reported an inverse correlation between systemic inflammation (measured as serum fibrinogen) and the integrity of brain structures involved in food reward and feeding behavior [73]. Most recently, diffusion tensor imaging was used to screen for hypothalamic damage in 44 obese patients and controls [74▪▪]. In the obese cohort, lower axon diffusivity (i.e., increased damage) was correlated with increased BMI and impaired cognitive performance. Finally, a few studies of structural alterations in the brains of obese patients have shown reduced connectivity through the corpus callosum [75,76], reduced hypothalamic volume in obese females with insulin resistance [77], and greater connectivity between the hypothalamus and reward-related brain areas than homeostatic areas [78▪]. Together, these data support the hypothesis that humans develop hypothalamic disease akin to that of rodents with gliosis and injury potentially promoting weight gain, insulin resistance, and cognitive impairment.

SUMMARY

The causes and consequences of hypothalamic inflammation and gliosis remain incompletely understood, but the field is progressing rapidly. Hypothalamic inflammation shares several common features with obesity-associated peripheral inflammation, but the involvement of unique CNS cell types identifies it as a fundamentally distinct process. Although there is considerable experimental support for a pathologic role of hypothalamic inflammation and gliosis, recent conflicting data have muddied the waters. Nevertheless, the preponderance of evidence in humans and animal models to date points to structural damage of the hypothalamic energy homeostasis center as a central deleterious consequence of diet-induced inflammation and gliosis and suggests an opportunity to reverse weight gain through manipulation of this complex multicellular process.

Acknowledgements

None.

Financial support and sponsorship

This work was supported by a mentor-based postdoctoral fellowship from the American Diabetes Association (ADA) to MDD and by an ADA Pathway to Stop Diabetes Grant 1–14-ACE-51 and NIDDK Career Development Award K08 K08DK088872 to JPT.

Conflicts of interest

There are no conflicts of interest.

REFERENCES AND RECOMMENDED READING

Papers of particular interest, published within the annual period of review, have been highlighted as:

  • ▪ of special interest
  • ▪▪ of outstanding interest

REFERENCES

1. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014; 311:74–86.
2. Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature 2000; 404:661–671.
3. Morton GJ, Cummings DE, Baskin DG, et al. Central nervous system control of food intake and body weight. Nature 2006; 443:289–295.
4. Cohn C, Joseph D. Influence of body weight and body fat on appetite of ‘normal’ lean and obese rats. Yale J Biol Med 1962; 34:598–607.
5. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292–295.
6▪▪. De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005; 146:4192–4199.

This study is the first report showing an association between obesity and hypothalamic inflammation.

7. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95:2409–2415.
8. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121:2111–2117.
9. Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell 2015; 161:146–160.
10. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009; 29:359–370.
11. Posey KA, Clegg DJ, Printz RL, et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 2009; 296:E1003–E1012.
12. Kleinridders A, Schenten D, Könner AC, et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009; 10:249–259.
13. Grayson BE, Levasseur PR, Williams SM, et al. Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology 2010; 151:1622–1632.
14▪. Morselli E, Fuente-Martin E, Finan B, et al. Hypothalamic PGC-1alpha protects against high-fat diet exposure by regulating ER alpha. Cell Rep 2014; 9:633–645.

The hypothalamic response to HFD is sexually dimorphic with male mice being predisposed to diet-induced hypothalamic inflammation from downregulation of estrogen signaling in neurons and astrocytes.

15▪▪. Valdearcos M, Robblee MM, Benjamin DI, et al. Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. Cell Rep 2014; 9:2124–2138.

This study identified microglia as the primary responders to dietary saturated fat and provided evidence that they are required for lipid-induced neuronal stress, hypothalamic inflammation, leptin resistance, and hyperphagia.

16. Weissmann L, Quaresma PG, Santos AC, et al. IKKepsilon is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity. Diabetes 2014; 63:3334–3345.
17. Maric T, Woodside B, Luheshi GN. The effects of dietary saturated fat on basal hypothalamic neuroinflammation in rats. Brain Behav Immun 2014; 36:35–45.
18▪▪. Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 2012; 122:153–162.

This study showed an increase in hypothalamic neuronal stress, inflammation, and gliosis during the first days of HFD exposure in rodents and found an association between hypothalamic gliosis and BMI in humans.

19. Ziko I, De Luca S, Dinan T, et al. Neonatal overfeeding alters hypothalamic microglial profiles and central responses to immune challenge long-term. Brain Behav Immun 2014; 41:32–43.
20. Wee YS, Weis JJ, Gahring LC, et al. Age-related onset of obesity corresponds with metabolic dysregulation and altered microglia morphology in mice deficient for Ifitm proteins. PloS One 2015; 10:e0123218.
21. Hu P, Thinschmidt JS, Yan Y, et al. CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am J Pathol 2013; 183:1608–1620.
22. Hu P, Thinschmidt JS, Caballero S, et al. Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice. Am J Physiol Endocrinol Metab 2015; 308:E688–E698.
23. de Kloet AD, Pioquinto DJ, Nguyen D, et al. Obesity induces neuroinflammation mediated by altered expression of the renin-angiotensin system in mouse forebrain nuclei. Physiol Behav 2014; 136:31–38.
24. Cano V, Valladolid-Acebes I, Hernandez-Nuno F, et al. Morphological changes in glial fibrillary acidic protein immunopositive astrocytes in the hippocampus of dietary-induced obese mice. Neuroreport 2014; 25:819–822.
25. Baquedano E, Ruiz-Lopez AM, Sustarsic EG, et al. The absence of GH signaling affects the susceptibility to high-fat diet-induced hypothalamic inflammation in male mice. Endocrinology 2014; 155:4856–4867.
26. Naznin F, Toshinai K, Waise TM, et al. Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation. J Endocrinol 2015; 226:81–92.
27. Pistell PJ, Morrison CD, Gupta S, et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 2010; 219 (1–2):25–32.
28. Jeon BT, Jeong EA, Shin HJ, et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012; 61:1444–1454.
29. Purkayastha S, Zhang G, Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-( and NF-(B. Nat Med 2011; 17:883–887.
30. Milanski M, Arruda AP, Coope A, et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 2012; 61:1455–1462.
31. Calegari VC, Torsoni AS, Vanzela EC, et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem 2011; 286:12870–12880.
32▪. Yan J, Zhang H, Yin Y, et al. Obesity- and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response. Nat Med 2014; 20:1001–1008.

This study demonstrated a mechanism of obesity-associated glucose intolerance involving CNS inflammation through atypical TGF-β signaling.

33▪. Balland E, Dam J, Langlet F, et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab 2014; 19:293–301.

Leptin transport across the BBB is disrupted during HFD feeding by excess extracellular signal-regulated kinase (ERK) phosphorylation in tanycytes.

34. Borg ML, Omran SF, Weir J, et al. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice. J Physiol 2012; 590 (Pt 17):4377–4389.
35. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009; 29:359–370.
36. Cheng L, Yu Y, Szabo A, et al. Palmitic acid induces central leptin resistance and impairs hepatic glucose and lipid metabolism in male mice. J Nutr Biochem 2015; 26:541–548.
37. Cheng L, Yu Y, Zhang Q, et al. Arachidonic acid impairs hypothalamic leptin signaling and hepatic energy homeostasis in mice. Mol Cell Endocrinol 2015; 412:12–18.
38. Portovedo M, Ignacio-Souza LM, Bombassaro B, et al. Saturated fatty acids modulate autophagy's proteins in the hypothalamus. PloS One 2015; 10:e0119850.
39. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009; 9:35–51.
40▪▪. Zhang X, Zhang G, Zhang H, et al. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008; 135:61–73.

Proinflammatory NF-κB signaling in hypothalamic neurons is activated by overnutrition. Disrupting this signaling in the brain or in specific hypothalamic neuron populations (AgRP) reduces inflammation, endoplasmic reticulum (ER) stress, leptin resistance, HFD intake, and body weight.

41. Kleinridders A, Schenten D, Konner AC, et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009; 10:249–259.
42. Moraes JC, Coope A, Morari J, et al. High-fat diet induces apoptosis of hypothalamic neurons. PloS One 2009; 4:e5045.
43. Li JM, Ge CX, Xu MX, et al. Betaine recovers hypothalamic neural injury by inhibiting astrogliosis and inflammation in fructose-fed rats. Mol Nutr Food Res 2015; 59:189–202.
44. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731–2738.
45▪. Lai M, Chandrasekera PC, Barnard ND. You are what you eat, or are you? The challenges of translating high-fat-fed rodents to human obesity and diabetes. Nutr Diabetes 2014; 4:e135.

A well written review of the problems with extrapolating mouse metabolic data to human nutrition and obesity.

46. Morari J, Anhe GF, Nascimento LF, et al. Fractalkine (CX3CL1) is involved in the early activation of hypothalamic inflammation in experimental obesity. Diabetes 2014; 63:3770–3784.
47. Buckman LB, Hasty AH, Flaherty DK, et al. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun 2014; 35:33–42.
48. Kierdorf K, Katzmarski N, Haas CA, Prinz M. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias. PloS One 2013; 8:e58544.
49. Yang Y, Jorstad NL, Shiao C, et al. Perivascular, but not parenchymal, cerebral engraftment of donor cells after nonmyeloablative bone marrow transplantation. Exp Mol Pathol 2013; 95:7–17.
50. Buckman LB, Thompson MM, Moreno HN, Ellacott KL. Regional astrogliosis in the mouse hypothalamus in response to obesity. J Comp Neurol 2013; 521:1322–1333.
51. Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 2014; 81:229–248.
52▪. Berkseth KE, Guyenet SJ, Melhorn SJ, et al. Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study. Endocrinology 2014; 155:2858–2867.

This study uses MRI scanning to demonstrate that diet-induced gliosis is potentially reversible.

53▪. Gao Y, Ottaway N, Schriever SC, et al. Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 2014; 62:17–25.

This article describes a careful comparative analysis of the differences between genetic and diet-induced obesity on microglial activation.

54. Horvath TL, Sarman B, García-Cáceres C, et al. Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc Natl Acad Sci U S A 2010; 107:14875–14880.
55. Fuente-Martin E, Garcia-Caceres C, Granado M, et al. Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J Clin Invest 2012; 122:3900–3913.
56▪. Reis WL, Yi CX, Gao Y, et al. Brain innate immunity regulates hypothalamic arcuate neuronal activity and feeding behavior. Endocrinology 2015; 156:1303–1315.

Microglia can modulate the electrical activity of energy homeostasis-regulating neurons and contribute to food intake regulation.

57. McNay DE, Briancon N, Kokoeva MV, et al. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J Clin Invest 2012; 122:142–152.
58▪. Kim JG, Suyama S, Koch M, et al. Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding. Nat Neurosci 2014; 17:908–910.

The first demonstration of a functional involvement of leptin signaling in glial cells in energy homeostasis regulation.

59▪. Yang L, Qi Y, Yang Y. Astrocytes control food intake by inhibiting AGRP neuron activity via adenosine A1 receptors. Cell Rep 2015; 11:798–807.

This study uses DREADD chemogenetic technology to demonstrate a role for astrocytes in the regulation of food intake.

60. Lee DA, Bedont JL, Pak T, et al. Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche. Nat Neurosci 2012; 15:700–702.
61. Chang Y, She ZG, Sakimura K, et al. Ablation of NG2 proteoglycan leads to deficits in brown fat function and to adult onset obesity. PloS One 2012; 7:e30637.
62. Guyenet SJ, Matsen ME, Morton GJ, et al. Rapid glutamate release in the mediobasal hypothalamus accompanies feeding and is exaggerated by an obesogenic food. Mol Metab 2013; 2:116–122.
63. Benzler J, Ganjam GK, Pretz D, et al. Central inhibition of IKKbeta/NF-kappaB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes 2015; 64:2015–2027.
64. Ito Y, Banno R, Shibata M, et al. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat diet. J Neurosci 2013; 33:17166–17173.
65. Arruda AP, Milanski M, Coope A, et al. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology 2011; 152:1314–1326.
66. Buckman LB, Thompson MM, Lippert RN, et al. Evidence for a novel functional role of astrocytes in the acute homeostatic response to high-fat diet intake in mice. Mol Metab 2015; 4:58–63.
67. Koch CE, Lowe C, Pretz D, et al. High-fat diet induces leptin resistance in leptin-deficient mice. J Neuroendocrinol 2014; 26:58–67.
68. Cai G, Dinan T, Barwood JM, et al. Neonatal overfeeding attenuates acute central pro-inflammatory effects of short-term high fat diet. Front Neurosci 2014; 8:446.
69. Wang X, Ge A, Cheng M, et al. Increased hypothalamic inflammation associated with the susceptibility to obesity in rats exposed to high-fat diet. Exp Diabetes Res 2012; 2012:847246.
70. Garcia-Caceres C, Fuente-Martin E, Diaz F, et al. The opposing effects of ghrelin on hypothalamic and systemic inflammatory processes are modulated by its acylation status and food intake in male rats. Endocrinology 2014; 155:2868–2880.
71. Kocalis HE, Turney MK, Printz RL, et al. Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARdelta) in mice leads to increased susceptibility to diet-induced obesity. PloS One 2012; 7:e42981.
72▪. Lemus MB, Bayliss JA, Lockie SH, et al. A stereological analysis of NPY, POMC, Orexin, GFAP astrocyte, and Iba1 microglia cell number and volume in diet-induced obese male mice. Endocrinology 2015; 156:1701–1713.

A carefully conducted immunohistochemical study of neuronal and glial responses to HFD-feeding questions previous findings regarding neuron loss and reactive gliosis.

73. Cazettes F, Cohen JI, Yau PL, et al. Obesity-mediated inflammation may damage the brain circuit that regulates food intake. Brain Res 2011; 1373:101–109.
74▪▪. Puig J, Blasco G, Daunis IEJ, et al. Hypothalamic damage is associated with inflammatory markers and worse cognitive performance in obese subjects. J Clin Endocrinol Metab 2015; 100:E276–E281.

The most convincing demonstration to date of hypothalamic structural abnormalities in obese humans.

75. Mueller K, Anwander A, Moller HE, et al. Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PloS One 2011; 6:e18544.
76. Stanek KM, Grieve SM, Brickman AM, et al. Obesity is associated with reduced white matter integrity in otherwise healthy adults. Obesity (Silver Spring) 2011; 19:500–504.
77. Ha J, Cohen JI, Tirsi A, Convit A. Association of obesity-mediated insulin resistance and hypothalamic volumes: possible sex differences. Dis Markers 2013; 35:249–259.
78▪. Kilpatrick LA, Coveleskie K, Connolly L, et al. Influence of sucrose ingestion on brainstem and hypothalamic intrinsic oscillations in lean and obese women. Gastroenterology 2014; 146:1212–1221.

A well designed and executed study using a caloric challenge to reveal differences between lean and obese women in connectivity of metabolically important brain areas.

Keywords:

gliosis; hypothalamus; inflammation; obesity

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.